GLP-1 use prior to surgery (N = 50)

Control Group (N = 50)

Mean Difference (95% CI)

p-value

Compared to pre-surgery weight

EBWL at 3 months

36.7 ± 11.5%

40.9 ± 11.1%

4.2 (-0.3 to 8.7)

0.0662

EBWL at 6 months

51.2 ± 15.0%

58.0 ± 16.1%

6.8 (0.6 to 13.0)

0.0313

EBWL at 9 months

59.4 ± 16.4%

65.8 ± 18.9%

6.4 (-0.6 to 13.4)

0.0736

EBWL at 12 months

64.2 ± 19.5%

68.8 ± 22.2%

4.6 (-3.7 to 12.9)

0.2737

Goal EBWL of ≥ 60%

reached

30 (60%)

33 (66%)

0.534

Use of GLP-1 agent after surgery

16 (32%)

7 (14%)

0.0325

Compared to consult weight

EBWL at 12 months

69.7 ± 16.9%

71.2 ± 20.9%

1.5 (-6.0 to 9.0)

0.694

Goal EBWL of ≥ 60%

reached

36 (72%)

41 (82%)

0.2351